nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—ATP4A—larynx—thyroid cancer	0.082	0.726	CbGeAlD
Esomeprazole—CYP2C19—Sorafenib—thyroid cancer	0.0732	0.388	CbGbCtD
Esomeprazole—CYP3A4—Vandetanib—thyroid cancer	0.0587	0.311	CbGbCtD
Esomeprazole—CYP3A4—Sorafenib—thyroid cancer	0.0354	0.187	CbGbCtD
Esomeprazole—ATP4A—neck—thyroid cancer	0.0217	0.193	CbGeAlD
Esomeprazole—CYP3A4—Doxorubicin—thyroid cancer	0.0215	0.114	CbGbCtD
Esomeprazole—ATP4A—head—thyroid cancer	0.00918	0.0813	CbGeAlD
Esomeprazole—Purpura—Doxorubicin—thyroid cancer	0.00072	0.00103	CcSEcCtD
Esomeprazole—Asthenia—Sorafenib—thyroid cancer	0.000716	0.00103	CcSEcCtD
Esomeprazole—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000711	0.00102	CcSEcCtD
Esomeprazole—Pruritus—Sorafenib—thyroid cancer	0.000706	0.00101	CcSEcCtD
Esomeprazole—Blood creatinine increased—Epirubicin—thyroid cancer	0.000703	0.00101	CcSEcCtD
Esomeprazole—Hyponatraemia—Doxorubicin—thyroid cancer	0.000697	0.000998	CcSEcCtD
Esomeprazole—Pain in extremity—Doxorubicin—thyroid cancer	0.000694	0.000994	CcSEcCtD
Esomeprazole—Diplopia—Doxorubicin—thyroid cancer	0.000694	0.000994	CcSEcCtD
Esomeprazole—Osteoarthritis—Doxorubicin—thyroid cancer	0.000694	0.000994	CcSEcCtD
Esomeprazole—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000694	0.000994	CcSEcCtD
Esomeprazole—Dry skin—Epirubicin—thyroid cancer	0.000688	0.000985	CcSEcCtD
Esomeprazole—Abdominal pain upper—Epirubicin—thyroid cancer	0.000685	0.000981	CcSEcCtD
Esomeprazole—Migraine—Doxorubicin—thyroid cancer	0.000683	0.000979	CcSEcCtD
Esomeprazole—Hypokalaemia—Epirubicin—thyroid cancer	0.000683	0.000978	CcSEcCtD
Esomeprazole—Diarrhoea—Sorafenib—thyroid cancer	0.000683	0.000978	CcSEcCtD
Esomeprazole—Breast disorder—Epirubicin—thyroid cancer	0.000678	0.000971	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000675	0.000968	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000675	0.000968	CcSEcCtD
Esomeprazole—Face oedema—Doxorubicin—thyroid cancer	0.00067	0.00096	CcSEcCtD
Esomeprazole—Gastritis—Epirubicin—thyroid cancer	0.000664	0.000951	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000662	0.000948	CcSEcCtD
Esomeprazole—Muscular weakness—Epirubicin—thyroid cancer	0.000662	0.000948	CcSEcCtD
Esomeprazole—Dizziness—Sorafenib—thyroid cancer	0.00066	0.000945	CcSEcCtD
Esomeprazole—Abdominal distension—Epirubicin—thyroid cancer	0.000653	0.000935	CcSEcCtD
Esomeprazole—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00065	0.000931	CcSEcCtD
Esomeprazole—Influenza—Epirubicin—thyroid cancer	0.000648	0.000929	CcSEcCtD
Esomeprazole—Asthma—Epirubicin—thyroid cancer	0.000648	0.000929	CcSEcCtD
Esomeprazole—Dysphagia—Epirubicin—thyroid cancer	0.000648	0.000929	CcSEcCtD
Esomeprazole—Dry skin—Doxorubicin—thyroid cancer	0.000636	0.000911	CcSEcCtD
Esomeprazole—Pancreatitis—Epirubicin—thyroid cancer	0.000636	0.00091	CcSEcCtD
Esomeprazole—Vomiting—Sorafenib—thyroid cancer	0.000634	0.000909	CcSEcCtD
Esomeprazole—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000634	0.000908	CcSEcCtD
Esomeprazole—Hypokalaemia—Doxorubicin—thyroid cancer	0.000632	0.000905	CcSEcCtD
Esomeprazole—Angina pectoris—Epirubicin—thyroid cancer	0.000632	0.000905	CcSEcCtD
Esomeprazole—Rash—Sorafenib—thyroid cancer	0.000629	0.000901	CcSEcCtD
Esomeprazole—Dermatitis—Sorafenib—thyroid cancer	0.000628	0.0009	CcSEcCtD
Esomeprazole—Breast disorder—Doxorubicin—thyroid cancer	0.000627	0.000898	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000625	0.000895	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000625	0.000895	CcSEcCtD
Esomeprazole—Headache—Sorafenib—thyroid cancer	0.000625	0.000895	CcSEcCtD
Esomeprazole—Pancytopenia—Epirubicin—thyroid cancer	0.000616	0.000882	CcSEcCtD
Esomeprazole—Gastritis—Doxorubicin—thyroid cancer	0.000614	0.00088	CcSEcCtD
Esomeprazole—Muscular weakness—Doxorubicin—thyroid cancer	0.000612	0.000877	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000612	0.000877	CcSEcCtD
Esomeprazole—Dysuria—Epirubicin—thyroid cancer	0.000606	0.000868	CcSEcCtD
Esomeprazole—Neutropenia—Epirubicin—thyroid cancer	0.000606	0.000868	CcSEcCtD
Esomeprazole—Abdominal distension—Doxorubicin—thyroid cancer	0.000604	0.000865	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000603	0.000863	CcSEcCtD
Esomeprazole—Asthma—Doxorubicin—thyroid cancer	0.0006	0.000859	CcSEcCtD
Esomeprazole—Influenza—Doxorubicin—thyroid cancer	0.0006	0.000859	CcSEcCtD
Esomeprazole—Dysphagia—Doxorubicin—thyroid cancer	0.0006	0.000859	CcSEcCtD
Esomeprazole—Pollakiuria—Epirubicin—thyroid cancer	0.000599	0.000858	CcSEcCtD
Esomeprazole—Nausea—Sorafenib—thyroid cancer	0.000593	0.000849	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000592	0.000848	CcSEcCtD
Esomeprazole—Weight increased—Epirubicin—thyroid cancer	0.00059	0.000845	CcSEcCtD
Esomeprazole—Pancreatitis—Doxorubicin—thyroid cancer	0.000588	0.000842	CcSEcCtD
Esomeprazole—Weight decreased—Epirubicin—thyroid cancer	0.000587	0.00084	CcSEcCtD
Esomeprazole—Angina pectoris—Doxorubicin—thyroid cancer	0.000584	0.000837	CcSEcCtD
Esomeprazole—Infestation—Epirubicin—thyroid cancer	0.000578	0.000828	CcSEcCtD
Esomeprazole—Infestation NOS—Epirubicin—thyroid cancer	0.000578	0.000828	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000573	0.000821	CcSEcCtD
Esomeprazole—Pancytopenia—Doxorubicin—thyroid cancer	0.00057	0.000816	CcSEcCtD
Esomeprazole—Renal failure—Epirubicin—thyroid cancer	0.000568	0.000814	CcSEcCtD
Esomeprazole—Jaundice—Epirubicin—thyroid cancer	0.000563	0.000807	CcSEcCtD
Esomeprazole—Stomatitis—Epirubicin—thyroid cancer	0.000563	0.000807	CcSEcCtD
Esomeprazole—Conjunctivitis—Epirubicin—thyroid cancer	0.000562	0.000805	CcSEcCtD
Esomeprazole—Urinary tract infection—Epirubicin—thyroid cancer	0.000562	0.000805	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—thyroid cancer	0.000561	0.000803	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—thyroid cancer	0.000561	0.000803	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000558	0.000799	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—thyroid cancer	0.000554	0.000794	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—thyroid cancer	0.000551	0.000789	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000548	0.000784	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000547	0.000783	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—thyroid cancer	0.000546	0.000782	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—thyroid cancer	0.000545	0.000781	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—thyroid cancer	0.000543	0.000777	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—thyroid cancer	0.000542	0.000777	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—thyroid cancer	0.000539	0.000773	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—thyroid cancer	0.000535	0.000766	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—thyroid cancer	0.000535	0.000766	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00053	0.00076	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—thyroid cancer	0.000528	0.000757	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—thyroid cancer	0.000526	0.000753	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—thyroid cancer	0.000521	0.000747	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—thyroid cancer	0.000521	0.000747	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—thyroid cancer	0.00052	0.000745	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—thyroid cancer	0.00052	0.000745	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—thyroid cancer	0.00052	0.000745	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—thyroid cancer	0.000519	0.000743	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—thyroid cancer	0.000516	0.00074	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—thyroid cancer	0.000515	0.000738	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—thyroid cancer	0.000512	0.000734	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—thyroid cancer	0.000511	0.000732	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—thyroid cancer	0.00051	0.00073	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—thyroid cancer	0.00051	0.00073	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—thyroid cancer	0.000509	0.000729	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000506	0.000725	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—thyroid cancer	0.000505	0.000723	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—thyroid cancer	0.000502	0.000719	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—thyroid cancer	0.0005	0.000716	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—thyroid cancer	0.000499	0.000715	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—thyroid cancer	0.000491	0.000703	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—thyroid cancer	0.000489	0.0007	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—thyroid cancer	0.000485	0.000695	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—thyroid cancer	0.000484	0.000693	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—thyroid cancer	0.000482	0.00069	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—thyroid cancer	0.000481	0.00069	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—thyroid cancer	0.00048	0.000688	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000478	0.000684	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—thyroid cancer	0.000477	0.000683	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000474	0.000679	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000473	0.000678	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000472	0.000676	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—thyroid cancer	0.000471	0.000674	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—thyroid cancer	0.000469	0.000671	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—thyroid cancer	0.000468	0.00067	CcSEcCtD
Esomeprazole—Chills—Epirubicin—thyroid cancer	0.000466	0.000667	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—thyroid cancer	0.000463	0.000663	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—thyroid cancer	0.000459	0.000657	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—thyroid cancer	0.000455	0.000651	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000454	0.00065	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—thyroid cancer	0.000452	0.000647	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—thyroid cancer	0.000449	0.000643	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—thyroid cancer	0.000448	0.000641	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—thyroid cancer	0.000446	0.000638	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—thyroid cancer	0.000445	0.000638	CcSEcCtD
Esomeprazole—Tension—Epirubicin—thyroid cancer	0.000443	0.000635	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—thyroid cancer	0.000442	0.000634	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—thyroid cancer	0.000439	0.000628	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—thyroid cancer	0.000437	0.000626	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—thyroid cancer	0.000434	0.000622	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—thyroid cancer	0.000434	0.000621	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000433	0.00062	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—thyroid cancer	0.000431	0.000617	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—thyroid cancer	0.000426	0.00061	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—thyroid cancer	0.000424	0.000608	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—thyroid cancer	0.000421	0.000603	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000419	0.0006	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—thyroid cancer	0.000418	0.000599	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—thyroid cancer	0.000418	0.000598	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—thyroid cancer	0.000415	0.000595	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—thyroid cancer	0.000412	0.00059	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—thyroid cancer	0.00041	0.000588	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—thyroid cancer	0.000409	0.000586	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—thyroid cancer	0.000407	0.000584	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—thyroid cancer	0.000406	0.000581	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—thyroid cancer	0.000406	0.000581	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—thyroid cancer	0.000404	0.000579	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—thyroid cancer	0.000404	0.000579	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—thyroid cancer	0.000402	0.000576	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—thyroid cancer	0.000399	0.000572	CcSEcCtD
Esomeprazole—Cough—Epirubicin—thyroid cancer	0.000394	0.000565	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—thyroid cancer	0.000394	0.000564	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—thyroid cancer	0.00039	0.000559	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000388	0.000556	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—thyroid cancer	0.000386	0.000553	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—thyroid cancer	0.000385	0.000551	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—thyroid cancer	0.000385	0.000551	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—thyroid cancer	0.000385	0.000551	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—thyroid cancer	0.000384	0.00055	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—thyroid cancer	0.000383	0.000549	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000382	0.000547	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—thyroid cancer	0.00038	0.000544	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—thyroid cancer	0.000377	0.00054	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—thyroid cancer	0.000376	0.000539	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—thyroid cancer	0.000376	0.000538	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—thyroid cancer	0.000374	0.000536	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—thyroid cancer	0.000372	0.000532	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—thyroid cancer	0.000369	0.000529	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—thyroid cancer	0.000369	0.000528	CcSEcCtD
Esomeprazole—Infection—Epirubicin—thyroid cancer	0.000366	0.000525	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—thyroid cancer	0.000365	0.000522	CcSEcCtD
Esomeprazole—Shock—Epirubicin—thyroid cancer	0.000363	0.00052	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—thyroid cancer	0.000362	0.000518	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000361	0.000517	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—thyroid cancer	0.000361	0.000517	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—thyroid cancer	0.00036	0.000515	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—thyroid cancer	0.000358	0.000513	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000356	0.000511	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—thyroid cancer	0.000356	0.00051	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—thyroid cancer	0.000356	0.00051	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—thyroid cancer	0.000356	0.00051	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—thyroid cancer	0.000355	0.000508	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000353	0.000506	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—thyroid cancer	0.000352	0.000504	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—thyroid cancer	0.000351	0.000503	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—thyroid cancer	0.000348	0.000498	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—thyroid cancer	0.000344	0.000493	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000341	0.000489	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—thyroid cancer	0.000339	0.000485	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000336	0.000481	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—thyroid cancer	0.000336	0.000481	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000335	0.000479	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000334	0.000478	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—thyroid cancer	0.000333	0.000478	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—thyroid cancer	0.000333	0.000477	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—thyroid cancer	0.000331	0.000475	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—thyroid cancer	0.000331	0.000474	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00033	0.000472	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—thyroid cancer	0.000329	0.000471	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—thyroid cancer	0.000328	0.000469	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—thyroid cancer	0.000325	0.000466	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—thyroid cancer	0.000325	0.000465	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—thyroid cancer	0.00032	0.000459	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000318	0.000456	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—thyroid cancer	0.000318	0.000455	CcSEcCtD
Esomeprazole—Pain—Epirubicin—thyroid cancer	0.000315	0.000452	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—thyroid cancer	0.000315	0.000452	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000311	0.000445	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—thyroid cancer	0.000309	0.000442	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—thyroid cancer	0.000306	0.000439	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—thyroid cancer	0.000304	0.000436	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—thyroid cancer	0.000304	0.000435	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—thyroid cancer	0.000303	0.000434	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000301	0.000432	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—thyroid cancer	0.0003	0.00043	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—thyroid cancer	0.000297	0.000425	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000295	0.000422	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—thyroid cancer	0.000294	0.000421	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—thyroid cancer	0.000293	0.00042	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—thyroid cancer	0.000292	0.000418	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—thyroid cancer	0.000292	0.000418	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—thyroid cancer	0.000291	0.000417	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—thyroid cancer	0.000291	0.000417	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000281	0.000403	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000279	0.0004	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—thyroid cancer	0.000272	0.000389	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—thyroid cancer	0.000271	0.000388	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—thyroid cancer	0.00027	0.000386	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—thyroid cancer	0.00027	0.000386	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—thyroid cancer	0.000265	0.000379	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—thyroid cancer	0.000261	0.000374	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—thyroid cancer	0.000252	0.000361	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—thyroid cancer	0.000251	0.00036	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—thyroid cancer	0.000245	0.000351	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—thyroid cancer	0.000244	0.000349	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—thyroid cancer	0.000241	0.000346	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—thyroid cancer	0.000234	0.000336	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—thyroid cancer	0.000233	0.000334	CcSEcCtD
Esomeprazole—Rash—Epirubicin—thyroid cancer	0.000232	0.000333	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—thyroid cancer	0.000232	0.000333	CcSEcCtD
Esomeprazole—Headache—Epirubicin—thyroid cancer	0.000231	0.000331	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—thyroid cancer	0.000226	0.000323	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—thyroid cancer	0.000219	0.000314	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—thyroid cancer	0.000217	0.000311	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—thyroid cancer	0.000215	0.000308	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—thyroid cancer	0.000215	0.000308	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—thyroid cancer	0.000214	0.000306	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—thyroid cancer	0.000203	0.00029	CcSEcCtD
